Institute for Clinical Pharmacodynamics

ICPD specializes in integrating preclinical and clinical pharmacokinetic/pharmacodynamic data to optimize antimicrobial drug development. The company provides advanced modeling, simulation, dose selection guidance, susceptibility breakpoint analysis, and regulatory support. Their work has contributed to pivotal decisions in antibiotic development programs but they do not have their own proprietary clinical pipeline. They have published results supporting the use of PK/PD modeling to improve dosing strategies and reduce risk during drug development. They are frequently involved with government agencies and industry partners on advisory panels. Example project involvement includes animal models of infection to study antifungal agents like isavuconazole. No direct proprietary clinical trial results or products.